VDA-1102, VDA-1102 placebo
VDA-CP-06 P2B
Phase 2 small_molecule active
Quick answer
VDA-1102, VDA-1102 placebo for Actinic keratosis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Actinic keratosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active